1. Home
  2. RES vs PCRX Comparison

RES vs PCRX Comparison

Compare RES & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$5.68

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.26

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
PCRX
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
RES
PCRX
Price
$5.68
$26.26
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$5.24
$32.86
AVG Volume (30 Days)
1.6M
723.2K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
0.22
0.47
Revenue
$1,536,150,000.00
$716,791,000.00
Revenue This Year
$16.11
$6.24
Revenue Next Year
$5.05
$9.53
P/E Ratio
$26.07
$55.78
Revenue Growth
4.20
3.14
52 Week Low
$4.10
$18.17
52 Week High
$7.17
$27.64

Technical Indicators

Market Signals
Indicator
RES
PCRX
Relative Strength Index (RSI) 59.47 72.55
Support Level $5.73 $23.63
Resistance Level $5.96 $24.81
Average True Range (ATR) 0.16 0.93
MACD 0.02 0.25
Stochastic Oscillator 67.90 100.00

Price Performance

Historical Comparison
RES
PCRX

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: